CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas

被引:0
|
作者
Katharina Baur
Andreas Buser
Lukas T. Jeker
Nina Khanna
Heinz Läubli
Dominik Heim
Jan C. Dirks
Corinne C. Widmer
Thomas Volken
Jakob R. Passweg
Andreas Holbro
机构
[1] University Hospital Basel,Division of Hematology
[2] University Hospital Basel,Innovation Focus on Cell Therapies
[3] Blood Transfusion Service,Department of Biomedicine
[4] Swiss Red Cross,Transplantation Immunology & Nephrology
[5] University Hospital and University of Basel,Division of Infectious Diseases and Hospital Epidemiology
[6] University Hospital Basel,Department of Internal Medicine, Division of Oncology
[7] University and University Hospital of Basel,Diagnostic Hematology
[8] University Hospital Basel,Department of Health Institute for Public Health
[9] University Hospital,undefined
[10] ZHAW Zurich University of Applied Science,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1048 / 1050
页数:2
相关论文
共 50 条
  • [1] CD4+CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas
    Baur, Katharina
    Buser, Andreas
    Jeker, Lukas T.
    Khanna, Nina
    Laeubli, Heinz
    Heim, Dominik
    Dirks, Jan C.
    Widmer, Corinne C.
    Volken, Thomas
    Passweg, Jakob R.
    Holbro, Andreas
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (09) : 1048 - 1050
  • [2] CAR T cell therapy for B-cell lymphomas
    Chavez, Julio C.
    Locke, Frederick L.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (02) : 135 - 146
  • [3] Associated Toxicities Assessment and management related to CAR T-cell therapy
    Anderson, Karen
    Latchford, Theresa
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (02) : 13 - 19
  • [4] CAR T-cell therapy for B-cell lymphoma
    Denlinger, Nathan
    Bond, David
    Jaglowski, Samantha
    [J]. CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [5] Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy
    Chow, Victor A.
    Gopal, Ajay K.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Stephen D.
    Shadman, Mazyar
    Cassaday, Ryan D.
    Till, Brian G.
    Tseng, Yolanda D.
    Warren, Edus H.
    Shustov, Andrei R.
    Menon, Manoj P.
    Kanan, Sandra
    Acharya, Utkarsh H.
    Mullane, Erin
    Hannan, Lindsay M.
    Voutsinas, Jenna M.
    Gooley, Ted
    Lynch, Ryan C.
    [J]. BLOOD, 2018, 132
  • [7] Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy
    Chow, Victor A.
    Gopal, Ajay K.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Stephen D.
    Ujjani, Chaitra S.
    Shadman, Mazyar
    Cassaday, Ryan D.
    Till, Brian G.
    Tseng, Yolanda D.
    Warren, Edus H.
    Shustov, Andrei R.
    Menon, Manoj P.
    Bhark, Sandra
    Acharya, Utkarsh H.
    Mullane, Erin
    Hannan, Lindsay M.
    Voutsinas, Jenna M.
    Gooley, Ted A.
    Lynch, Ryan C.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) : E209 - E213
  • [8] Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
    Chong, Elise A.
    Alanio, Cecile
    Svoboda, Jakub
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Lacey, Simon F.
    Ruella, Marco
    Bhattacharyya, Siddharth
    Wherry, E. John
    Schuster, Stephen J.
    [J]. BLOOD, 2022, 139 (07) : 1026 - 1038
  • [9] CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
    Chavez, Julio C.
    Bachmeier, Christina
    Kharfan-Dabaja, Mohamed A.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 20
  • [10] Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy
    Chong, Elise A.
    Ruella, Marco
    Schuster, Stephen J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 673 - 674